News Updates
Regenerative medicine and war: The next breakthrough in treating injured veterans?
Source: Genetic Literacy Project
The most significant development in recent years for severely maimed veterans and other victims of physical injuries is the acceleration of what’s known as regenerative medicine. Regenerative medicine was first defined in 1999 and it encompasses many disciplines of science. Its goal is to provide clinicians with the tools to effectively repair or replace a patient’s damaged tissues and organs in order to return normal function.
Researchers develop nanoclay-based bioprinting method to produce functional bone implants
Source: 3D Printing Industry
Using 3D printers, researchers have collaborated from around the globe to develop nanoclay-based 3D bioprinted scaffolds which could be used to aid skeletal regeneration.
How groups of cells cooperate to build organs and organisms
Source: The Scientist
Understanding biology’s software—the rules that enable great plasticity in how cell collectives generate reliable anatomies—is key to advancing tissue engineering and regenerative medicine.
Self-eating' Process of Stem Cells May Be the Key to New Regenerative Therapies
Source: Science Daily
The self-eating process in embryonic stem cells known as chaperone-mediated autophagy (CMA) and a related metabolite may serve as promising new therapeutic targets to repair or regenerate damaged cells and organs, researchers show.
Stem Cells for Everyone: Revolutionizing Regenerative Medicine with Mass Manufacturing of Induced Pluripotent Stem Cells (iPSCs)
Source: PR Newswire
I Peace, Inc. (CEO: Koji Tanabe, https://ipeace.com/), a Palo Alto-based biotech startup focusing on Nobel Prize-wining technology of induced pluripotent stem cells (iPSCs) has successfully developed a novel system to mass manufacture clinical-grade iPSCs for cell therapy in a palm-size closed cassette.
Stem Cell Therapy a Possible Treatment for Rheumatoid Arthritis
Source: Healthline
As the world of stem cell research advances, more options may become available to patients with RA and other autoimmune diseases.
Stem Cell Osteoarthritis Studies Advance
Source: Pain News Network
A Canadian doctor is recruiting patients for a "first of its kind" stem cell research project for osteoarthritis. The Phase II study could further advance the use of regenerative medicine in treating osteoarthritis, a joint disease for which treatment options are currently limited to pain medication, steroid injections or joint replacement surgery.
